If you’ve been side-eyeing a Le Labo bottle and wondering whether the brand will still be around and investing in quality five years from now, here’s your answer: the numbers back it up.
Per Now Smell This, Estée Lauder forecast annual profit above Wall Street estimates this week, and the company was direct about what’s carrying the weight — luxury fragrance and skincare. Not makeup (flat). Not hair care (declining). Fragrance. The company specifically called out Le Labo and Balmain Beauty as the products drawing spend from both affluent customers and younger buyers who are prioritizing scent over almost every other category of beauty.
This wasn’t marketing spin — it’s what the company told investors when explaining why its stock jumped nearly 7% in premarket trading.
What’s Actually Driving This
Rich people still buying expensive things isn’t news — the more interesting signal is the younger customer cohort. Fragrance has quietly become the prestige beauty purchase that younger consumers reach for first, ahead of skincare and well ahead of cosmetics. A bottle of Le Labo Santal 33 is a considered, identity-driven buy at a price that still reads as accessible next to a luxury handbag. That math works for a generation that understands what quality perfumery costs and is willing to pay for it.
Estée Lauder owns a significant slice of the brands that sit in that sweet spot — prestigious enough to feel special, present enough in culture to feel relevant. Le Labo has independent-feeling credibility that most conglomerate-owned brands have tried and failed to manufacture. Balmain Beauty is newer and riding a fashion house halo. Both are performing.
The failed merger conversations with Puig — the group behind Jean Paul Gaultier — collapsing in May add some context too. Estée Lauder was clearly looking to expand its fragrance portfolio further. That deal didn’t happen, but the underlying logic was sound: fragrance is where the growth is, and you buy it where you can find it.
What This Means for the Brands You’re Actually Shopping
If you’re considering a bottle from an Estée Lauder-owned line, the financials suggest these brands are being invested in, not wound down. Le Labo in particular has been the clearest example of a house that’s maintained its quality positioning under corporate ownership — the store experience, the personalization ritual, the refill system. None of that happens if the parent company is treating the brand as a cash cow to be milked and neglected.
AERIN Beauty Mediterranean Honeysuckle Rollerball sits at the more accessible, lifestyle end of Estée Lauder’s fragrance portfolio — a light, easy honeysuckle built for the kind of person who thinks of fragrance as a finishing touch rather than a collection centerpiece. It’s not Le Labo, but it benefits from the same corporate support structure and supply chain that keeps these lines consistent year over year.
The Bond No. 9 Wall Street mention is more tangential — Bond No. 9 isn’t an Estée Lauder property — but it’s a useful reference point for what the “prestige fragrance for a specific identity” model looks like. Bond No. 9 built its entire brand around place-as-identity storytelling, and Le Labo has done something structurally similar with city editions. Buyers who respond to that kind of specificity are exactly the consumer Estée Lauder’s results say are spending.
The Broader Point for Fragrance Buyers
Economic uncertainty has a way of sorting beauty categories fast. Makeup and hair care — both flagging in Estée Lauder’s numbers — are easy to trade down on. You can swap a prestige foundation for a drugstore one and mostly be fine. Fragrance is stickier, partly because the emotional attachment runs deeper, and partly because cheap alternatives genuinely don’t perform the same way. A cheap body spray is not a replacement for a well-made eau de parfum with a real drydown. Consumers seem to know this.
The China growth story matters too, though it’s less immediately relevant to most readers here. What it tells you is that luxury fragrance demand is geographically broadening, not concentrating. That broader base of buyers is what makes it easier for brands to justify the R&D and material investment that keeps quality up.
The Verdict
If you’ve been sitting on a Le Labo purchase waiting for a sign that the house isn’t about to quietly decline under Estée Lauder’s ownership, this is probably as close to a green light as financial news gets. The company is betting its recovery on fragrance. That means investment, not neglect.
Buy the bottle. The category is healthy, the parent company is motivated to keep it that way, and waiting rarely makes fragrance decisions easier — it usually just makes them more expensive.
